Literature DB >> 7931594

Optic pathway glioma infiltrating into somatostatinergic pathways in a young boy with gigantism. Case report.

T J Manski1, C S Haworth, B J Duval-Arnould, E J Rushing.   

Abstract

The authors report gigantism in a 16-month-old boy with an extensive optic pathway glioma infiltrating into somatostatinergic pathways, as revealed by magnetic resonance imaging and immunocytochemical studies. Stereotactic biopsies of areas showing hyperintense signal abnormalities on T2-weighted images in and adjacent to the involved visual pathways provided rarely obtained histological correlation of such areas. The patient received chemotherapy, which resulted in reduction of size and signal intensity of the tumor and stabilization of vision and growth velocity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931594     DOI: 10.3171/jns.1994.81.4.0595

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Optic pathway glioma and endocrine disorders in patients with and without NF1.

Authors:  Merav Gil Margolis; Michal Yackobovitz-Gavan; Helen Toledano; Ariel Tenenbaum; Roni Cohen; Moshe Phillip; Shlomit Shalitin
Journal:  Pediatr Res       Date:  2022-05-10       Impact factor: 3.756

2.  Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone Excess.

Authors:  Fady Hannah-Shmouni; Giampaolo Trivellin; Pablo Beckers; Lefkothea P Karaviti; Maya Lodish; Christina Tatsi; Adekunle M Adesina; Fotini Adamidou; Gesthimani Mintziori; Jami L Josefson; Martha Quezado; Constantine A Stratakis
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

Review 3.  Genetics of gigantism and acromegaly.

Authors:  Fady Hannah-Shmouni; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Growth Horm IGF Res       Date:  2016-08-10       Impact factor: 2.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.